The Derms on Drugs Bust Myths and Make Life Easier for Derms This Week episode artwork

EPISODE · Feb 20, 2026 · 56 MIN

The Derms on Drugs Bust Myths and Make Life Easier for Derms This Week

from Derms on Drugs · host Scholars in Medicine

Big news on TB Tests for psoriasis patients on biologics! New official recommendations say not necessary for IL-17s and IL-23s.  Literally zero cases.  Ever.  Think nicotinamide prevents skin cancer?  Think again.  Not saying it doesn't, but turns out data isn't really there and the jury is still out. How safe are topical steroids?  Depends.  Depends what else you're taking, especially NSAIDS - turns out it may increase your risk of an upper GI pretty substantially.If somebody doesn't respond adequately to Dupixent, what happens if you switch them to Rinvoq?  Abbvie kind of answered the question, but not really.Just how well does Rhapsido work in CSU?  And does it actually cause bleeding? No, no it does not.  But we're understanding more and more about why it causes petechiae.  Are PDE4 inhibitors like apremilast and roflumilast effective for bullous pemphigoid?  Maybe.  Do Sotyktu (and the new TYK2 inhibitors coming soon) work for atopic dermatitis?  We got our first data and it looks like they are pretty great. 

Episode metadata supplied by the publisher feed · Published Feb 20, 2026

Embed this episode

NOW PLAYING

The Derms on Drugs Bust Myths and Make Life Easier for Derms This Week

0:00 56:04

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Derms on Drugs?

This episode is 56 minutes long.

When was this Derms on Drugs episode published?

This episode was published on February 20, 2026.

Can I download this Derms on Drugs episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!